Thrombotic Microangiopathies — Defibrotide TMA Prophylaxis Pilot Trial
Citation(s)
A Pilot Trial of Using Pre-Transplant Risk Stratification and Prophylactic Defibrotide to Prevent Serious Thrombotic Microangiopathy in High-Risk Hematopoietic Stem Cell Transplant Patients